Sign in

CIK 0001021561

  • Accelerated filer

NU SKIN ENTERPRISES, INC.

Sign in to watch
Ticker
NUS
Exchange
NYSE
Industry
Wholesale-Drugs, Proprietaries & Druggists' Sundries
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
870565309
Phone
+1 801-345-1000
Business address
75 WEST CENTER ST, ATTN: GREGORY BELLISTON, PROVO, UT, 84601
Former names
NU SKIN ENTERPRISES INC, NU SKIN ASIA PACIFIC INC, NU SKIN ASIA INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-02-15 Lawrence Mark H Chief Financial Officer Shares withheld for taxes −5,139 $49.65 $255K 42,705
2022-02-15 NAPIERSKI RYAN S President and CEO Shares withheld for taxes −4,498 $49.65 $223K 91,070
2022-02-11 Hatchett Steven Keith Chief Product Officer Grant or award · Employee Stock Option (Right to Buy) +10,554 21,108
2022-02-11 Hatchett Steven Keith Chief Product Officer Grant or award · Employee Stock Option (Right to Buy) +4,879 4,879
2022-02-11 Thomas James D Chief Accounting Officer Grant or award · Employee Stock Option (Right to Buy) +9,002 9,002
2022-02-11 Thomas James D Chief Accounting Officer Grant or award · Employee Stock Option (Right to Buy) +2,710 2,710
2022-02-11 Clark Chayce David EVP and General Counsel Grant or award · Employee Stock Option (Right to Buy) +4,390 4,390
2022-02-11 Clark Chayce David EVP and General Counsel Grant or award · Employee Stock Option (Right to Buy) +1,431 1,431
2022-02-11 Clark Chayce David EVP and General Counsel Grant or award · Employee Stock Option (Right to Buy) +3,118 3,118
2022-02-11 CHANG JOSEPH Y Chief Scientific Officer Grant or award · Employee Stock Option (Right to Buy) +33,060 66,118
2022-02-11 CHANG JOSEPH Y Chief Scientific Officer Grant or award · Employee Stock Option (Right to Buy) +10,840 10,840
2022-02-11 Lawrence Mark H Chief Financial Officer Grant or award · Employee Stock Option (Right to Buy) +46,560 93,122
2022-02-11 Lawrence Mark H Chief Financial Officer Grant or award · Employee Stock Option (Right to Buy) +14,906 14,906
2022-02-11 NAPIERSKI RYAN S President and CEO Grant or award · Employee Stock Option (Right to Buy) +70,540 141,080
2022-02-11 NAPIERSKI RYAN S President and CEO Grant or award · Employee Stock Option (Right to Buy) +21,883 21,883
2022-01-24 LIPMAN ANDREW D Director Sale −1,000 $50.50 $51K 74,214
2021-12-08 WOODBURY EDWINA D Director Grant or award +12 $46.19 $554 13,476
2021-10-05 Bettinger Jeffrey Clark SVP, People and Places Officer Sale −1,625 $41.10 $67K 16,068
2021-10-01 Bettinger Jeffrey Clark SVP, People and Places Officer Shares withheld for taxes −1,498 $41.48 $62K 17,693
2021-09-13 CHANG JOSEPH Y EVP, Chief Scientific Officer Exercise or conversion +16,000 $30.63 $490K 33,942

Page 16 of 25 · 487 trades